相关实验视频

Updated: Jun 19, 2025

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

对于局部高级直肠癌的新辅助疗法的现状

Sonal S Noticewala¹, Prajnan Das

¹From the Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Cancer journal (Sudbury, Mass.)

|July 23, 2024

概括

对直肠癌的新辅助疗法已发展成为全方位的新辅助疗法,整合了手术前的辐射和化疗. 这种方法旨在最大限度地提高瘤反应,并改善局部晚期直肠癌的生存结果.

科学领域:

在瘤学瘤学.
手术瘤学手术瘤学
胃肠病学胃肠病学

背景情况:

对局部晚期直肠癌的新辅助治疗已经显著发展.
最初的方法不涉及任何手术前治疗,进展到放射和全身疗法.

研究的目的:

审查局部晚期直肠癌的新辅助治疗策略的演变.
突出全面新辅助疗法的好处和选择标准.

主要方法:

对直肠癌治疗中新辅助方法的文献综述.
分析治疗的演变,从单一疗法到联合疗法.

主要成果:

总的新辅助疗法 (TNT) 代表了最新的进步,在手术前完成了所有手术前治疗.
TNT旨在优化瘤反应并提高患者的存活率.

结论:

总的新辅助疗法是管理局部晚期直肠癌的关键发展.
仔细选择患者对于优化新辅助性直肠癌治疗结果至关重要.

更多相关视频

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...